Total Payments
$28,624
2024 Payments
$6,500
Companies
17
Transactions
82
Medicare Patients
780
Medicare Billing
$56,359
Payment Breakdown by Category
Consulting$25,500 (89.1%)
Food & Beverage$3,064 (10.7%)
Other$59.53 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $25,500 | 4 | 89.1% |
| Food and Beverage | $3,064 | 77 | 10.7% |
| Entertainment | $59.53 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Atlas Ocular, Inc | $25,500 | 4 | $0 (2024) |
| Allergan, Inc. | $884.36 | 25 | $0 (2021) |
| Shire North American Group Inc | $575.22 | 12 | $0 (2019) |
| Alcon Laboratories Inc | $481.08 | 6 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $320.70 | 7 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $259.41 | 8 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $142.96 | 3 | $0 (2020) |
| Genentech USA, Inc. | $132.09 | 1 | $0 (2018) |
| Eyevance Pharmaceuticals LLC | $60.08 | 4 | $0 (2020) |
| Optos, Inc. | $59.53 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,500 | 1 | Atlas Ocular, Inc ($6,500) |
| 2023 | $6,000 | 1 | Atlas Ocular, Inc ($6,000) |
| 2022 | $5,500 | 1 | Atlas Ocular, Inc ($5,500) |
| 2021 | $7,532 | 3 | Atlas Ocular, Inc ($7,500) |
| 2020 | $296.53 | 12 | Aerie Pharmaceuticals, Inc. ($157.96) |
| 2019 | $924.67 | 24 | Allergan Inc. ($304.52) |
| 2018 | $1,049 | 23 | Allergan Inc. ($479.08) |
| 2017 | $820.80 | 17 | Shire North American Group Inc ($347.62) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Atlas Ocular, Inc | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| 01/15/2023 | Atlas Ocular, Inc | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 02/14/2022 | Atlas Ocular, Inc | — | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| 01/27/2021 | Allergan, Inc. | RESTASIS MULTIDOSE (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: DRY EYE | ||||||
| 01/25/2021 | Atlas Ocular, Inc | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 01/14/2021 | Kala Pharmaceuticals, Inc. | INVELTYS (Drug), EYSUVIS | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Ocular | ||||||
| 12/03/2020 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/01/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: DRY EYE | ||||||
| 11/16/2020 | Eyevance Pharmaceuticals LLC | Flarex (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ophthalmic | ||||||
| 10/30/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: GLAUCOMA | ||||||
| 09/11/2020 | Eyevance Pharmaceuticals LLC | Flarex (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: ophthalmic | ||||||
| 07/01/2020 | Allergan, Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: GLAUCOMA | ||||||
| 06/29/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Glaucoma | ||||||
| 05/21/2020 | Allergan, Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: DRY EYE | ||||||
| 03/11/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $116.36 | General |
| Category: Glaucoma | ||||||
| 01/31/2020 | Eyevance Pharmaceuticals LLC | Flarex (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: ophthalmic | ||||||
| 01/28/2020 | Aerie Pharmaceuticals, Inc. | rocklatan (Drug), rhopressa | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Glaucoma | ||||||
| 01/28/2020 | Allergan, Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/21/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Glaucoma | ||||||
| 12/12/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/04/2019 | Alcon Vision LLC | AcrySof (Device) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: Ophthalmology | ||||||
| 11/26/2019 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: DRY EYE | ||||||
| 11/15/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Glaucoma | ||||||
| 11/05/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $99.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/30/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 134 | 144 | $28,675 | $6,613 |
| 2020 | 10 | 646 | 742 | $138,795 | $49,746 |
Total Patients
780
Total Services
886
Medicare Billing
$56,359
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 88 | 98 | $20,580 | $5,369 | 26.1% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 16 | 16 | $1,920 | $701.85 | 36.6% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 13 | 13 | $2,860 | $366.16 | 12.8% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2021 | 17 | 17 | $3,315 | $175.69 | 5.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 272 | 359 | $75,390 | $34,518 | 45.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 32 | 32 | $7,040 | $3,332 | 47.3% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 65 | 66 | $7,920 | $3,314 | 41.8% |
| 92250 | Photography of the retina | Office | 2020 | 75 | 78 | $11,700 | $2,851 | 24.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 39 | $5,460 | $1,525 | 27.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 41 | 43 | $9,470 | $1,323 | 14.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 18 | $2,160 | $865.53 | 40.1% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 23 | 23 | $5,060 | $759.09 | 15.0% |
| 76514 | Ultrasound of corneal structure and measurement | Office | 2020 | 67 | 67 | $13,065 | $654.56 | 5.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 15 | 17 | $1,530 | $602.59 | 39.4% |
About Dr. Samuel Stopak, M.D
Dr. Samuel Stopak, M.D is a Ophthalmology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669514428.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Stopak, M.D has received a total of $28,624 in payments from pharmaceutical and medical device companies, with $6,500 received in 2024. These payments were reported across 82 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($25,500).
As a Medicare-enrolled provider, Stopak has provided services to 780 Medicare beneficiaries, totaling 886 services with total Medicare billing of $56,359. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Washington, DC
- Active Since 02/12/2007
- Last Updated 07/04/2012
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669514428
Products in Payments
- XIIDRA (Drug) $718.18
- LUMIGAN (Drug) $606.49
- ReSTOR (Device) $401.69
- LOTEMAX SM (Drug) $213.16
- rocklatan (Drug) $157.96
- Lucentis (Biological) $132.09
- OZURDEX (Drug) $131.98
- Rhopressa (Drug) $101.45
- ALREX (Drug) $92.19
- ACTIVEFOCUS (Device) $79.39
- RESTASIS (Drug) $62.80
- Flarex (Drug) $60.08
- California (Device) $59.53
- LOTEMAX GEL (Drug) $50.71
- DURYSTA (Drug) $33.06
- AcrySof (Device) $32.83
- Prokera (Device) $30.40
- SYMPHONY (Device) $21.10
- CEQUA (Drug) $20.63
- INVELTYS (Drug) $19.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Washington
Dr. Wiley Chambers, M.d, M.D
Ophthalmology — Payments: $174,000
Ophthalmology $174,000
Keesha Williams-Elliott, M.d, M.D
Ophthalmology — Payments: $148,955
Ophthalmology $148,955
Dr. Dipak Panigrahi, Md, MD
Ophthalmology — Payments: $95,574
Ophthalmology $95,574
Dr. Michael Korenfeld, Md, MD
Ophthalmology — Payments: $78,793
Ophthalmology $78,793
Leslie Jones, Md, MD
Ophthalmology — Payments: $29,248
Ophthalmology $29,248
Richard North, Md, MD
Ophthalmology — Payments: $20,477
Ophthalmology $20,477